Respiri Limited
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a RSH.AX research report →
Price Chart
About the company
Based in Melbourne, Australia, Respiri Limited operates as an e-health software-as-a-service (SaaS) provider. The company is dedicated to the research, development, and commercialization of medical devices across Australia, and also creates, manufactures, and distributes mobile health applications. Its key offerings include wheezo, an innovative electronic tool specifically designed for identifying wheezing in children, along with the Respiri mobile application and the Respiri health portal.
- CEO
- Marjan Mikel
- IPO
- 2000
- Employees
- 2
- HQ
- Melbourne, VIC, AU
Get TickerSpark's AI analysis on RSH.AX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $51.98M
- P/E
- -4.71
- PEG
- -0.05
- P/S
- 113.77
- P/B
- 12.74
- EV/EBITDA
- -7.50
- Div Yield
- 0.00%
- Gross Margin
- 99.16%
- Op Margin
- -1673.36%
- Net Margin
- -1560.30%
- ROE
- -411.64%
- ROIC
- -191.13%
Latest fiscal year · YoY change
- Revenue
- $456.91K+547.8%
- Gross Profit
- $453.06K+118.5%
- Op Income
- $-7,645,835
- Net Income
- $-7,129,247-23.4%
- EPS
- $-0.01+2.8%
- OCF Growth
- -47.9%
- FCF Growth
- -47.2%
- 52W High
- $0.10
- 52W Low
- $0.02
- 50D MA
- $0.04
- 200D MA
- $0.05
- Beta
- -0.44
- RSI (14)
- 52
- Avg Volume
- 870.34K
No earnings-call transcripts are available for RSH.AX yet.
- Free Float
- 65.1%
- Shares Outstanding
- 1.58B
- Float Shares
- 1.03B
Our RSH.AX coverage
Recent articles, reports, and earnings notes.
No research on RSH.AX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate RSH.AX report →